Related Experiment Video

Updated: Aug 15, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Antibiotic-resistant pneumococci in the United Kingdom

R C George, L C Ball, P G Cooper

    Communicable Disease Report. CDR Review
    |March 27, 1992
    PubMed

    Insights

    Antimicrobial resistance in Streptococcus pneumoniae is increasing, impacting treatment of pneumococcal infections like pneumonia and meningitis. This trend necessitates updated antimicrobial therapy and vaccination strategies.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Antimicrobial Resistance

    Background:

    • Pneumococcal pneumonia and meningitis cause significant illness and death.
    • Traditional antibiotics like penicillins, cephalosporins, erythromycin, and chloramphenicol are standard treatments.
    • Increasing antimicrobial resistance in Streptococcus pneumoniae is a global concern.

    Purpose of the Study:

    • To review antimicrobial susceptibility and serotyping data for UK Streptococcus pneumoniae isolates over five years.
    • To assess the trends in antibiotic resistance and serotypes of referred pneumococcal isolates.
    • To discuss the implications for clinical treatment and public health vaccination policies.

    Main Methods:

    • Analysis of antimicrobial susceptibility testing results.
    • Review of serotyping studies on Streptococcus pneumoniae isolates.
    • Data collected from UK Streptococcus and Antibiotic Reference Laboratories over a five-year period.

    Main Results:

    • A significant increase in pneumococcal isolates resistant to commonly used antimicrobials was observed.
    • Referral rates of resistant pneumococcal strains to reference laboratories have markedly increased.
    • Specific trends in resistance patterns and serotypes were identified.

    Conclusions:

    • Rising antimicrobial resistance poses a challenge to effective treatment of pneumococcal infections.
    • Current vaccination policies may need re-evaluation in light of changing resistance patterns.
    • Urgent consideration of alternative therapeutic strategies and updated vaccination approaches is required.

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

    Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

    Published on: September 11, 2020

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...